Q2 2021

Filed Aug 9, 2021 · 10-Q · 40 days after period end · 0001493152-21-019036

Q2 2021 · 10-Q

Revenue

$1.04M

+231.6% vs Q2 2020

Net Income

-$3.51M

N/M vs Q2 2020

EPS Diluted

-$0.46

N/M vs Q2 2020

Gross Profit$262,000N/M

Operating Income

Same quarter

Metric	Q2 2021	Q2 2020	Q2 2019	Q2 2018
Revenue	$1.04M	$313.00K	$1.35M	$1.00M
Net Income	-$3.51M	-$2.48M	-$2.21M	-$627.00K
EPS Diluted	-$0.46	-$2.93	-$1.59	-$7.66

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR